The clinical result is a coordinated reduction in antral contractility and increased pyloric resistance, leading to prolonged gastric residence times for both liquids and solids [17]
This is one reason two people can follow the same weight loss plan and experience different results
The most common adverse reactions for Wegovy (incidence 5%) in adults or pediatric patients aged 12 years and older are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss
BPC-157 does not act through a single receptor like a conventional drug